22nd Century CEO & Chairman Larry Firestone Provides Technology and Regulatory Update Letter to Stockholders

About this update from 22nd Century Group, Inc

[{"type":"image","alt":"22nd Century Group, Inc.","displaySize":"","headline":null,"caption":"22nd Century Group, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":49,"url":"https://media.zenfs.com/en/globenewswire.com/1bea5c3c79110e918b41c982afc348cd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/U47lMnIUnLY0CmcSoKscPA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY5O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/1bea5c3c79110e918b41c982afc348cd","width":300,"height":49}},"lazy":false},{"type":"text","content":"MOCKSVILLE, N.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addition, today issued the following letter to stockholders from Larry Firestone, the Chief Executive Officer of 22nd Century Group, Inc.:","length":364,"tagName":"p"},{"type":"text","content":"A Letter to Our Shareholders","length":28,"tagName":"p"},{"type":"text","content":"We recently released our second quarter 2025 earnings, along with important corporate updates regarding the ongoing launch and rollout of VLN® products. VLN® cigarettes are the first and only combustible tobacco product purposefully designed to reduce the harms of smoking and authorized by the U.S. Food and Drug Administration.","length":329,"tagName":"p"},{"type":"text","content":"Perhaps one of the most exciting updates in that report was the early adoption of our VLN® approach by two well-established partner brands, Smoker Friendly and Pinnacle, with more expected to follow. The initial Pinnacle VLN® stocking orders were shipped in August, bringing reduced nicotine content options to even more smokers looking for new ways to reduce their smoking habit.","length":380,"tagName":"p"},{"type":"text","content":"In addition to accelerating growth and achieving profitability, we are also driving important initiatives in the technology and regulatory landscape. I want to share more on those efforts and how they will help us to maintain and expand our industry leading position in the very low nicotine plant genetics and bioscience space.","length":328,"tagName":"p"},{"type":"text","content":"FDA Proposed Rule – September 15, 2025","length":38,"tagName":"p"},{"type":"text","content":"The FDA’s proposed new Tobacco ...

More updates from 22nd Century Group, Inc